Literature DB >> 16239693

Hypercalcaemia in cancer.

Simon Conroy1, Brendan O'Malley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16239693      PMCID： PMC1261196          DOI： 10.1136/bmj.331.7522.954

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  7 in total

Review 1.  Hyperparathyroid and hypoparathyroid disorders.

Authors:  S J Marx
Journal:  N Engl J Med       Date:  2000-12-21       Impact factor: 91.245

2.  Malignancy and concomitant primary hyperparathyroidism.

Authors:  W E Strodel; N W Thompson; F E Eckhauser; J A Knol
Journal:  J Surg Oncol       Date:  1988-01       Impact factor: 3.454

3.  Dose-response relationships for radiation-induced hyperparathyroidism.

Authors:  A B Schneider; T C Gierlowski; E Shore-Freedman; M Stovall; E Ron; J Lubin
Journal:  J Clin Endocrinol Metab       Date:  1995-01       Impact factor: 5.958

Review 4.  Primary hyperparathyroidism in the older person.

Authors:  Simon Conroy; Sophie Moulias; Wassif S Wassif
Journal:  Age Ageing       Date:  2003-11       Impact factor: 10.668

5.  Survival in hypercalcaemic patients with cancer and co-existing primary hyperparathyroidism.

Authors:  A C Hutchesson; N J Bundred; W A Ratcliffe
Journal:  Postgrad Med J       Date:  1995-01       Impact factor: 2.401

6.  Hyperparathyroidism and subsequent incidence of breast cancer.

Authors:  Karin B Michels; Fei Xue; Lena Brandt; Anders Ekbom
Journal:  Int J Cancer       Date:  2004-06-20       Impact factor: 7.396

7.  Primary hyperparathyroidism associatiated with aldosterone-producing adrenocortical adenoma and breast cancer: relation to MEN1 gene.

Authors:  Munehiro Honda; Toshihiko Tsukada; Toshimitsu Horiuchi; Reiko Tanaka; Ken Yamaguchi; Takao Obara; Hiroshi Miyakawa; Tohru Yamaji; Miyuki Ishibashi
Journal:  Intern Med       Date:  2004-04       Impact factor: 1.271
  7 in total
  1 in total

1.  Malignancy associated hypercalcaemia-responsiveness to IV bisphosphonates and prognosis in a palliative population.

Authors:  Shreyashee Mallik; Girijasankar Mallik; Shireen Teves Macabulos; Andrew Dorigo
Journal:  Support Care Cancer       Date:  2015-10-06       Impact factor: 3.603
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.